… related to their uses including ocular diseases such as cataract, glaucoma and a global …
, followed by 20.3% through oral therapy, 16% used inhaled steroid therapy and 4.3% used …

… We sought to understand if inhaled corticosteroid (ICS) use … ), diabetes and ocular disorder
(glaucoma or cataracts). Study … case-control study of cataract and inhaled corticosteroids. Br J …

… In sufficient dosages, they also produce bone mineral loss leading to osteoporosis and might
increase the risk of cataracts, glaucoma, skin atrophy, and vascular changes that increase …

… Side effects associated with long-term ICS use include reduction in growth velocity, cataracts,
glaucoma, osteoporosis, and fractures. Fear of unwanted complications may be of concern …

… cataract formation. The occurrence of posterior subcapsular cataracts with ICS and oral steroid
… might be helpful in defining a definitive link between ICS use and glaucoma in the elderly. …

… increased the risk of cataracts and glaucoma, although the … of cataracts was correlated to
prednisone but not ICS use. A … , suggested that the risk of cataracts with ICS may be related to …

… Cataracts and glaucoma ICS exposure was not associated with increased odds of
cataracts or glaucoma, nor was a dose–response relationship observed in this population-based …

… been implicated in the development of glaucoma and cataracts.'?'!' Because nasal steroids
are usually administered in much smaller doses than inhaled steroids, a lower incidence of …

… In addition to possible cataract formation, osteoporosis, glaucoma, and growth retardation
are possible adverse effects.The challenge now is to provide informational labeling to point …

… topical or even inhaled corticosteroids. The rapid withdrawal of corticosteroids may also lead
… Cataract, glaucoma and the potentiation of infection are serious ocular side effects. Topical …